Pharmacists in La Vernia, TX Accepting Medicare

6 Pharmacists found. Showing 1 - 6

Carmen Hoffman, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 13857 Us Highway 87 W Ste 100, La Vernia, TX 78121 Phone: 830-779-2219

Dr. Gabriel O Aguilar, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 14414 Us Highway 87 W, La Vernia, TX 78121 Phone: 830-779-3730    Fax: 830-779-4190

Pamela Todd Malone Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6488 Fm 775, La Vernia, TX 78121 Phone: 830-779-3730    Fax: 830-779-4190

Brandi N Drzymala, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 14414 Us Highway 87 W, La Vernia, TX 78121 Phone: 830-779-3109

Emily Shumard Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 14414 Us Highway 87 W, La Vernia, TX 78121 Phone: 830-779-3109

Monica Kunde, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 14414 Us Highway 87 W, La Vernia, TX 78121 Phone: 830-779-3730    Fax: 866-499-8852

News Archive

Central Logic relocates corporate headquarters to new facility in South Jordan, Utah

Central Logic, the healthcare industry's leading provider of innovative patient flow software and consultative expertise, today announced the relocation of its corporate headquarters to South Jordan, Utah. The new facility, located at 10653 South River Front Parkway in the recently-constructed RiverPark Corporate Center, comfortably accommodates the company's current corporate staff and operations, both of which have increased significantly in the past 18 months, and effectively facilitates additional expansion in conjunction with future growth and development.

Risks and benefits of computed tomography in young adults

The underlying medical conditions facing young adults who undergo computed tomography (CT) exams represent a significantly greater health risk than that of radiation-induced cancer from CT, according to a new study published online in the journal Radiology.

Acceleron commences ACE-536 phase 2 study in myelodysplastic syndromes

Acceleron Pharma, Inc., a biopharmaceutical company developing protein therapeutics for cancer and orphan diseases, today announced the initiation of a phase 2 study of its investigational protein therapeutic, ACE-536, to treat anemia in patients with myelodysplastic syndromes (MDS).

Viewpoints: Ryan responds to Obama; calling Ryan's 'bluff'; 'magical solutions'

This week the House of Representatives will take the first real step in addressing our looming fiscal crisis by bringing "The Path to Prosperity," a budget resolution for next year and beyond, to the House floor. This budget offers a clear contrast to the president's speech on Wednesday. … [A] deficit speech that doesn't even rise to the level of a plan. Missing was a credible way to curb out-of-control spending.

Scientists continue work to end chemotherapy pain

With this year's $600,000 grant from the Leukemia & Lymphoma Society and $1.5 million grant from the NIH, a Saint Louis University investigator is continuing her work to end chemotherapy pain. Noted pain researcher Daniela Salvemini, Ph.D., is using the funding to capitalize on her recent finding published in Pain, a breakthrough that helps scientists understand a molecular pathway by which pain occurs with certain anti-cancer drugs.

Read more Medical News

› Verified 9 days ago